We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
INDV

Price
14.01
Stock movement up
+0.11 (0.79%)
Company name
Indivior PLC Ordinary Shares
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
1.75B
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
6.78%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
7.55
PEG
-
EPS growth
-
1 year return
-14.26%
3 year return
58.18%
5 year return
73.94%
10 year return
14.65%
Last updated: 2025-08-27

DIVIDENDS

INDV does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open13.92
Daily high14.47
Daily low13.89
Daily Volume879K
All-time high24.77
1y analyst estimate28.00
Beta0.96
EPS (TTM)-
Dividend per share0.95
Ex-div date16 Jun 2016
Next earnings date23 Oct 2025

Downside potential

Loading...
Downside potential data
INDVS&P500
Current price drop from All-time high-43.45%-3.04%
Highest price drop-93.82%-56.47%
Date of highest drop11 Apr 20199 Mar 2009
Avg drop from high-41.96%-11.04%
Avg time to new high23 days12 days
Max time to new high1097 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
INDV (Indivior PLC Ordinary Shares) company logo
Marketcap
1.75B
Marketcap category
Small-cap
Description
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Employees
1000
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Semi-annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...